全文获取类型
收费全文 | 2842篇 |
免费 | 363篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 118篇 |
妇产科学 | 34篇 |
基础医学 | 211篇 |
口腔科学 | 29篇 |
临床医学 | 434篇 |
内科学 | 802篇 |
皮肤病学 | 62篇 |
神经病学 | 438篇 |
特种医学 | 299篇 |
外科学 | 255篇 |
综合类 | 39篇 |
一般理论 | 1篇 |
预防医学 | 140篇 |
眼科学 | 16篇 |
药学 | 215篇 |
中国医学 | 2篇 |
肿瘤学 | 133篇 |
出版年
2023年 | 54篇 |
2022年 | 21篇 |
2021年 | 43篇 |
2020年 | 98篇 |
2019年 | 24篇 |
2018年 | 100篇 |
2017年 | 83篇 |
2016年 | 84篇 |
2015年 | 86篇 |
2014年 | 119篇 |
2013年 | 143篇 |
2012年 | 107篇 |
2011年 | 100篇 |
2010年 | 109篇 |
2009年 | 133篇 |
2008年 | 90篇 |
2007年 | 97篇 |
2006年 | 103篇 |
2005年 | 77篇 |
2004年 | 77篇 |
2003年 | 70篇 |
2002年 | 86篇 |
2001年 | 69篇 |
2000年 | 62篇 |
1999年 | 73篇 |
1998年 | 94篇 |
1997年 | 101篇 |
1996年 | 87篇 |
1995年 | 76篇 |
1994年 | 54篇 |
1993年 | 57篇 |
1992年 | 46篇 |
1991年 | 38篇 |
1990年 | 38篇 |
1989年 | 71篇 |
1988年 | 57篇 |
1987年 | 43篇 |
1986年 | 36篇 |
1985年 | 35篇 |
1984年 | 32篇 |
1983年 | 21篇 |
1982年 | 19篇 |
1981年 | 17篇 |
1980年 | 21篇 |
1979年 | 17篇 |
1977年 | 14篇 |
1976年 | 17篇 |
1975年 | 14篇 |
1971年 | 16篇 |
1970年 | 15篇 |
排序方式: 共有3244条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
G N Hortobagyi D Frye F A Holmes V Hug G Fraschini A U Buzdar 《Cancer treatment reports》1987,71(12):1193-1196
Thirty patients with progressive metastatic breast cancer and one prior chemotherapy regimen were treated with iproplatin at a starting dose of 300 mg/m2 iv every 3 weeks. After the first 11 patients, the starting dose was decreased to 270 mg/m2. There were one complete remission, three partial remissions, and two minor responses. Responses were observed in soft tissue and osseous and visceral areas. Grade 3 nausea and vomiting were observed in 38% of patients, and grade 3 diarrhea occurred in 31%. The dose-limiting toxicity was thrombocytopenia, which required dose de-escalation in 15 patients. No nephrotoxicity, neurotoxicity, or ototoxicity was observed. Iproplatin has modest antitumor activity in this group of previously treated patients with metastatic breast cancer. 相似文献
6.
7.
R L Frye R Kronmal H V Schaff W O Myers B J Gersh 《International journal of cardiology》1992,36(2):213-221
An analysis of the Coronary Artery Surgery Registry (CASS) was performed to determine the occurrence of stroke after coronary artery bypass surgery in patients entered into the Coronary Artery Surgery Study Registry. Of the 10,098 patients having coronary artery bypass surgery at the Coronary Artery Surgery Study participating sites during the period July 1974 through May 1979, a total of 348 patients (or 3.4%) sustained a stroke during the first year after coronary bypass surgery. Fifty-nine strokes occurred on the day of surgery, and an additional 129 strokes occurred during hospitalization for coronary bypass surgery. Thus, 188 patients (1.9%) of the entire surgical group sustained a stroke during initial hospitalization for coronary artery bypass surgery. Logistic regression analysis was used to predict stroke on the day of surgery, during the hospitalization for surgery, and during the first year after surgery. The most powerful predictors of stroke on the day of coronary artery bypass surgery were: 1) older age (n = less than 0.0001); 2) use of alpha-adrenergic drugs after bypass (n = 0.0001); and 3) longer duration of cardiopulmonary bypass (n = 0.002). For those strokes occurring at least 1 day after coronary artery bypass but during the initial hospitalization, age and duration of cardiopulmonary bypass were the most powerful predictors of stroke. An analysis of predictors of stroke within 1 yr after hospital dismissal for initial coronary bypass surgery revealed that the most powerful predictor was a history of previous cerebrovascular disease (n less than 0.0001) and a history of hypertension (n less than 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
8.
9.
Through a multicenter registry of patients in the Coronary Artery Surgery Study, we prospectively evaluated morbidity and mortality in 4,165 smokers with angiographically proved coronary artery disease, 2,675 of whom continued to smoke and 1,490 of whom quit. At five years, mortality (adjusted by Cox analysis for baseline differences) was 22% for those who continued smoking and 15% for quitters. The relative risk (also from the Cox analysis) for mortality in continuers vs quitters was 1.55 (95% confidence interval, 1.29 to 1.85). The adverse effect of smoking mainly took the form of higher frequencies of myocardial infarction--associated death and sudden death: the frequencies of these events during follow-up in continuers vs quitters were 7.9% vs 4.4% for myocardial infarction--associated death and 2.8% vs 1.5% for sudden death. This study supports the recommendation that patients with coronary artery disease should stop smoking. 相似文献
10.